NeoGenomics, Inc. Payments of Debt Issuance Costs
NeoGenomics, Inc. (NEO) reported Payments of Debt Issuance Costs of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2022-02-25
- NeoGenomics, Inc. payments of debt issuance costs for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- NeoGenomics, Inc. payments of debt issuance costs for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- NeoGenomics, Inc. payments of debt issuance costs for the quarter ending 2019-12-31 was $8.00K.
- NeoGenomics, Inc. payments of debt issuance costs for the quarter ending 2019-09-30 was $97.00K.
- NeoGenomics, Inc. payments of debt issuance costs for fiscal 2021 was $0.00.
- NeoGenomics, Inc. payments of debt issuance costs for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- NeoGenomics, Inc. payments of debt issuance costs for fiscal 2019 was $1.06M, a 83.85% increase from fiscal 2018.
- NeoGenomics, Inc. payments of debt issuance costs for fiscal 2018 was $576.00K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-25 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | $0.00 10-K · filed 2022-02-25 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-07-31 | |||
| 2019-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $105.00K derived: sum of 2 quarters · filed 2022-02-25 | $1.06M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $1.05M 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | $954.00K 10-Q · filed 2020-07-31 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $576.00K 10-K · filed 2021-02-25 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $576.00K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $576.00K 10-Q · filed 2019-08-07 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $0.00 10-K · filed 2020-02-28 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-06 | |||
| 2016-12-31 | $2.20M 10-K · filed 2019-02-26 | |||
| 2015-12-31 | $3.35M 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |